natgillin/translations-raw huggingface dataset:
In exceptional circumstances in adults, when travel is anticipated within one month or more after initiating the vaccination course, but where insufficient time is available to allow the standard 0, 1, 6 month schedule to be completed, a schedule of three intramuscular injections given at 0, 7 and 21 days may be used.
V izjemnih okoliščinah, kadar je potovanje predvideno en mesec ali več po prvem odmerku cepiva in ni na voljo dovolj časa za standardno (0, 1, 6) shemo cepljenja, lahko pri odraslih uporabimo shemo treh zaporednih intramuskularnih injekcij, apliciranih na 0., 7. in 21. dan.
The need for a booster dose of hepatitis B vaccine in healthy individuals who have received a full primary vaccination course has not been established; however some official vaccination programmes currently include a recommendation for a booster dose of hepatitis B vaccine and these should be respected.
Pri zdravih osebah, ki so prejele celotno osnovno shemo cepljenja, ni potrebno poživitveno cepljenje s cepivom proti hepatitisu B. Kljub temu nekateri uradni programi cepljenja vsebujejo priporočilo za poživitveno cepljenje s cepivom proti hepatitisu B in ta priporočila je potrebno upoštevati.
For some categories of subjects or patients exposed to HBV (e.g; haemodialysis or immunocompromised patients) a precautionary attitude should be considered to ensure a protective antibody level ≥ 10IU/l.
Pri nekaterih kategorijah oseb ali bolnikov, izpostavljenih HBV (npr. bolniki na hemodializi ali imunsko pomanjkljive osebe), je zaradi zagotovitve zaščitnega nivoja protiteles ≥ 10 i.e./l potrebna posebna previdnost.
• Loss of skin sensitivity to pain or touch (hypoaesthesia)
• zmanjšana občutljivost za bolečino ali dotik (hipestezija),
Signs of an allergic reaction may include itchy skin rash, shortness of breath and swelling of the face or tongue.
Znaki alergijske reakcije lahko vključujejo srbeč kožni izpuščaj, težave z dihanjem (zasoplost) in zatekanje obraza ali jezika.
What Twinrix Adult is and what it is used for What you need to know before you receive Twinrix Adult How Twinrix Adult is given
Kaj je cepivo Twinrix za odrasle in za kaj ga uporabljamo Kaj morate vedeti, preden boste cepljeni s cepivom Twinrix za odrasle Kako uporabljati cepivo Twinrix za odrasle
• you are allergic to: - the active substances or any of the other ingredients of this medicine (listed in section 6).
- zdravilne učinkovine ali katero koli sestavino tega cepiva (navedeno v poglavju 6).
When this schedule is applied, a fourth dose is recommended 12 months after the first dose.
Kadar je uporabljena ta shema cepljenja, je priporočljivo dati še 4. odmerek cepiva 12 mesecev po aplikaciji prvega odmerka.
The severity and type of symptoms can vary.
Jakost in vrsta simptomov se od bolnika do bolnika lahko razlikujeta.
In the two clinical trials in which Twinrix Adult was administered at 0, 7, 21 days, overall solicited general and local symptoms were reported with the same categories of frequency as defined below.
V dveh kliničnih študijah, kjer so osebe prejele Twinrix za odrasle po pospešeni shemi (0, 7, 21 dan), so poročali o splošnih in lokalnih učinkih z isto kategorijo pogostnosti, kot je tu prikazano.
What Twinrix Adult is and what it is used for
Kaj je cepivo Twinrix za odrasle in za kaj ga uporabljamo
The virus is found in body fluids such as blood, semen, vaginal secretions, or saliva (spit) of infected people.
Virus hepatitisa B je prisoten v telesnih tekočinah, kot so kri, sperma, vaginalni izločki ali slina (izpljunek) okuženih ljudi.
Although the concomitant administration of Twinrix Adult and other vaccines has not specifically been studied, it is anticipated that, if different syringes and other injection sites are used, no interaction will be observed.
Čeprav hkratnega dajanja cepiva Twinrix za odrasle in drugih cepiv niso posebej preučevali, ob uporabi različnih injekcijskih brizg in pri injiciranju na različna mesta interakcija ni predvidena.
• you have a bleeding problem or bruise easily.
• imate težave s krvavitvami ali hitrim nastankom modric.
• Generally feeling unwell
• splošno slabo počutje.
In the event of either being observed, do not administer the vaccine.
Če opazite kar koli od navedenega, cepiva ne smete uporabiti.
HBsAg is produced by culture, in a selective medium, of genetically engineered yeast cells.
HBsAg je pridobljen z gensko tehnologijo na kulturi celic kvasovk v selektivnem mediju.
The doctor will give Twinrix Adult as an injection into your upper arm muscle.
Zdravnik vam bo dal cepivo Twinrix za odrasle v obliki injekcije v mišico nadlakti.
1 ml of suspension in a pre-filled syringe (type I glass) with a plunger stopper (rubber butyl).
1 ml suspenzije v napolnjeni injekcijski brizgi (steklo tipa I) z batnim zamaškom (butilna guma).
In haemodialysis patients and persons with an impaired immune system, adequate anti-HAV and anti-HBs antibody titres may not be obtained after the primary immunisation course and such patients may therefore require administration of additional doses of vaccine.
Pri bolnikih na hemodializi in osebah s slabšim imunskim odzivom po osnovnem cepljenju morda ne bo dosežen ustrezen titer protiteles antiHAV in anti-HBs, zato bodo tovrstni bolniki morda potrebovali dodatne odmerke cepiva.
• Purple or red brown spots visible through the skin (thrombocytopenic purpura)
• rdeče ali rdečerjave lise, ki se vidijo skozi kožo (trombocitopenična purpura),
In two long term clinical studies conducted in adults aged 17 years to 43 years, 56 subjects had evaluable tests 15 years after the primary vaccination with Twinrix Adult; the anti-HAV seropositivity rates were 100% in both studies and the anti-HBs seroprotection rates were 89.3% and 92.9%, respectively.
V dveh dolgotrajnih kliničnih raziskavah izvedenih pri odraslih osebah, starih od 17 do 43 let, so pri 56 osebah 15 let po primarnem cepljenju s cepivom Twinrix za odrasle s testi določili, da je bila antiHAV seropozitivnost 100% v obeh raziskavah, stopnji anti-HBs serološke zaščite pa sta bili 89,3% oziroma 92,9% glede na vsako reziskavo.
Hepatitis A virus (inactivated)1,2
Virus hepatitisa A (inaktivirani)1,2
In the clinical studies, specific humoral antibodies against hepatitis A were observed in approximately 94% of the adults one month after the first dose and in 100% one month after the third dose (i.e. month 7).
V kliničnih študijah so specifična humoralna protitelesa proti hepatitisu A ugotovili pri približno 94 % odraslih oseb en mesec po aplikaciji prvega odmerka cepiva in pri 100 % oseb en mesec po aplikaciji tretjega odmerka (to je mesec 7).
0.4 milligrams Al
0,4 miligrama Al
• Flu-like symptoms such as high temperature, sore throat, runny nose, cough and chills
• gripi podobna bolezen, kot so visoka telesna temperatura, vneto grlo, smrkavost, kašelj in mrzlica.
• Inflammation of nerves (neuritis)
• vnetje živcev (nevritis),
Inspect the vaccine again: a. If the vaccine appears as a uniform hazy white suspension, it is ready to use - the appearance should not be clear.
a. če je cepivo enotna, motno bela suspenzija, je pripravljeno za uporabo - videz ne sme biti bister;
LIST OF EXCIPIENTS Sodium chloride Water for injections
SEZNAM POMOŽNIH SNOVI natrijev klorid voda za injekcije
Twinrix Adult is for intramuscular injection, preferably in the deltoid region.
Twinrix za odrasle se injicira intramuskularno, najbolje v deltoidni predel.
The standard primary course of vaccination with Twinrix Adult consists of three doses, the first administered at the elected date, the second one month later and the third six months after the first dose.
Standardno osnovno cepljenje s cepivom Twinrix za odrasle sestoji iz treh odmerkov: prvi odmerek apliciramo na izbrani dan cepljenja, drugi odmerek sledi 1 mesec po prvem cepljenju in tretji odmerek 6 mesecev po prvem cepljenju.
(thrombocytopenia)
(trombocitopenija),
The effect of Twinrix Adult on embryo-fetal, peri-natal and post-natal survival and development has been assessed in rats.
Vpliv cepiva Twinrix za odrasle na embriofetalno, perinatalno in postnatalno preživetje ter razvoj so ovrednotili pri podganah.
Twinrix Adult has no or negligible influence on the ability to drive and use machines.
4.7 Vpliv na sposobnost vožnje in upravljanja s stroji Twinrix za odrasle nima ali ima zanemarljiv vpliv na sposobnost vožnje in upravljanja s stroji.
It is not known if Twinrix Adult passes into breast milk, however the vaccine is not expected to cause problems in breast-fed babies.
Ni znano, če cepivo Twinrix za odrasle prehaja v materino mleko, vendar pa težav pri dojenih otrocih ne pričakujemo.
Seropositivity rates for anti-HAV antibodies were 100%, 99.5% and 100% at months 1, 2 and 3 after the initial dose.
Stopnja seropozitivnosti za anti-HAV protitelesa je bila 100 % en mesec, 99,5 % dva meseca in 100 % tri mesece po prvem odmerku.
• Hepatitis B: Hepatitis B is caused by the hepatitis B virus.
• Hepatitis B: Hepatitis B povzroča virus hepatitisa B. Jetra otečejo (vnetje).
However, exceptionally Twinrix Adult can be administered subcutaneously to subjects with thrombocytopenia or bleeding disorders since bleeding may occur following an intramuscular administration to these subjects (see section 4.2).
Izjemoma se Twinrix za odrasle lahko daje subkutano in sicer bolnikom s trombocitopenijo in bolnikom z motnjami strjevanja krvi, ker lahko pri njih po intramuskularnem injiciranju nastopi krvavitev (glejte poglavje 4.2).
1 dose (1 ml)
(1 ml).
Other medicines and Twinrix Adult
Druga zdravila in cepivo Twinrix za odrasle
The seropositivity rate for anti-HAV antibodies after Twinrix Adult was 97% at both 7 and 48 months versus 99% and 93% after the GlaxoSmithKline Biologicals monovalent hepatitis A vaccine and 99% and 97% after another licensed monovalent hepatitis A vaccine.
Stopnja seropozitivnosti za protitelesa anti-HAV po dajanju cepiva Twinrix za odrasle je bila 97 % po 7 in po 48 mesecih, v primerjavi z 99 in 93 % po dajanju monovalentnega cepiva proti hepatitisu A izdelovalca GlaxoSmithKline Biologicals ter 99 in 97 % po dajanju nekega drugega monovalentnega cepiva proti hepitatisu A z dovoljenjem za promet.
Name and address of the manufacturer of the biological active substances
Ime in naslov izdelovalca biološke zdravilne učinkovine (učinkovin)
Abnormal liver function tests * refers to adverse reactions observed in clinical trials performed with the paediatric formulation
Preiskave nenormalne vrednosti preiskav jetrne funkcije *se nanaša na splošne reakcije, ki se lahko pojavijo v kliničnih preskusih z cepivom za otroke
In comparative studies, it was noted that the frequency of solicited adverse events following the administration of Twinrix Adult is not different from the frequency of solicited adverse events following the administration of the monovalent vaccines.
V raziskavi, ki je primerjala pogostnost neželenih dogodkov po aplikaciji cepiva Twinrix za odrasle in po aplikaciji monovalentnih cepiv, so opazili, da se pogostnosti neželenih dogodkov, po katerih so bile cepljene osebe vprašane, med seboj ne razlikujejo.
• Low blood pressure
• izguba apetita, • nizek krvni tlak,
Twinrix Adult is not recommended for postexposure prophylaxis (e.g. needle stick injury).
Twinrix za odrasle ni priporočljiv za zaščito po predhodni izpostavljenosti (npr. po vbodu z iglo).
• Serious allergic reactions (anaphylaxis, anaphylactoid reactions and mimicking serum sickness).
• hude alergijske reakcije (anafilaksija, anafilaktoidna reakcija in serumski bolezni podobna reakcija).
• Drooping eyelid and sagging muscles on one side of the face (facial palsy)
• povešena veka in mlahave mišice na eni strani obraza (paraliza obraza),
1Produced on human diploid (MRC-5) cells 2Adsorbed on aluminium hydroxide, hydrated
1Pridobljen na humanih diploidnih celicah (MRC-5) 2Adsorbiran na hidratirani aluminijev hidroksid
In situations where a booster dose of both hepatitis A and hepatitis B are desired, Twinrix Adult can be given.
V okoliščinah, ko je zaželen poživitveni odmerek proti hepatitisu A in tudi proti hepatitisu B, se lahko uporabi cepivo Twinrix za odrasle.
Contents of the pack and other information What Twinrix Adult contains
Vsebina pakiranja in dodatne informacije Kaj vsebuje cepivo Twinrix za odrasle
A dose of 1.0 ml is recommended for adults and adolescents 16 years of age and above.
Za odrasle in mladostnike, stare 16 let in več, je priporočljiv odmerek 1,0 ml.
PHARMACEUTICAL FORM AND CONTENTS Suspension for injection in pre-filled syringe 1 pre-filled syringe
FARMACEVTSKA OBLIKA IN VSEBINA Suspenzija za injiciranje v napolnjeni injekcijski brizgi 1 napolnjena injekcijska brizga 1 odmerek (1 ml)
METHOD AND ROUTE(S) OF ADMINISTRATION Read the package leaflet before use Intramuscular use
POSTOPEK IN POT(I) UPORABE ZDRAVILA Pred uporabo preberite priloženo navodilo.
EXPIRY DATE EXP: MM/YYYY
DATUM IZTEKA ROKA UPORABNOSTI ZDRAVILA EXP: MM/LLLL
It is unknown whether Twinrix Adult is excreted in human breast milk.
Ni znano, če se cepivo Twinrix za odrasle izloča v materino mleko.
It is not yet fully established whether immunocompetent individuals who have responded to hepatitis A vaccination will require booster doses as protection in the absence of detectable antibodies may be ensured by immunological memory.
Še vedno ni popolnoma dognano, če imunsko kompetentne osebe, ki so se odzvale na cepljenje s cepivom proti hepatitisu A, potrebujejo poživitveni odmerek, saj kljub temu, da se protiteles ne zazna,
Influenza like illness, chills
redki gripi podobna bolezen, mrzlica
The anti-HBs and anti-HAV antibody titres observed following a primary vaccination course with the combined vaccine are in the range of what is seen following vaccination with the monovalent vaccines.
Titri anti-HBs in anti-HAV protiteles, opaženi po osnovnem cepljenju, so primerljivi z opažanji po cepljenju z monovalentnimi cepivi.
The safety profile presented below is based on a pooled analysis of events per dose from more than 6,000 subjects who received either the standard 0, 1, 6 month schedule (n=5,683) or the accelerated 0, 7, 21 days schedule (n=320).
ki so bile cepljene po standardni shemi (0, 1, 6 mesec) (n=5,683) ali pospešeni shemi (0, 7, 21 dan) cepljenja (n=320).
Twinrix Adult should under no circumstances be administered intravascularly.
Cepiva Twinrix za odrasle se v nobenem primeru ne sme dajati v žilo.
Twinrix Adult confers immunity against HAV and HBV infection by inducing specific anti-HAV and anti-HBs antibodies.
Twinrix za odrasle omogoča imunost proti virusom hepatitisa A in hepatitisa B z indukcijo specifičnih anti-HAV in anti-HBs protiteles.
• Abnormal laboratory liver test results
• nenormalne vrednosti preiskav jetrne funkcije,
However, when the monovalent hepatitis A and hepatitis B vaccines were administered concomitantly with specific immunoglobulins, no influence on seroconversion was observed although it may result in lower antibody titres.
ali hepatitisu B dani hkrati s specifičnimi imunoglobulini, ni bilo opaziti vpliva na serokonverzijo, čeprav so titri protiteles lahko nižji.
Angioneurotic oedema, lichen planus, erythema multiforme
Bolezni kože in podkožja angionevrotični edem, lichen planus, multiformni eritem
Twinrix Adult contains neomycin Please tell your doctor if you have had an allergic reaction to neomycin (antibiotic).
Obvestite zdravnika, če ste kdaj imeli alergijsko reakcijo na neomicin (antibiotik).
swelling of the eyes and face, difficulty in breathing or swallowing, a sudden drop in blood pressure and loss of consciousness.
Znaki hude alergijske reakcije so lahko izpuščaji, ki so lahko srbeči ali mehurjasti, oteklina okrog oči in obraza, težave pri dihanju in požiranju, nenaden padec krvnega tlaka in izguba zavesti.
Alternatively, subjects primed with Twinrix Adult may be administered a booster dose of either of the monovalent vaccines.
Osebe, cepljene s cepivom Twinrix za odrasle, lahko prejmejo poživitveni odmerek posameznega monovalentnega cepiva.
The excretion of Twinrix Adult in milk has not been studied in animals.
Študije izločanja cepiva Twinrix za odrasle v mleko pri živalih niso bile izvedene.
Concentrations (GMC) increased by 179-fold (GMC of 7234 mIU/ml) indicative of an immune memory response.
(GMC 7.234 mi.e./ml), kar kaže na imunski spominski odziv.
If not, your doctor will advise you on the possible need to have extra doses.
Če odziv ni zadovoljiv, vam bo zdravnik morda svetoval cepljenje z dodatnimi odmerki.
In a clinical trial where Twinrix Adult was administered according to this schedule, 82% and 85% of vaccinees had seroprotective levels of anti-HBV antibodies at 1 and 5 weeks respectively following the third dose (i.e. at months 1 and 2 after the initial dose).
V klinični raziskavi so uporabili to shemo cepljenja in ugotovili, da je imelo 82 % cepljenih oseb zaščitni nivo anti-HBV protiteles v 1. tednu in 85 % cepljenih oseb v 5. tednu po aplikaciji tretjega odmerka (to je en in dva meseca po prvem odmerku).
• Swelling or infection of the brain (encephalitis)
• oteklost ali okužba možganov (encefalitis),
Each injection is given on a separate visit.
Ambulanto morate obiskati za vsak odmerek posebej.
Post-marketing surveillance
Izkušnje v obdobju trženja
Make sure you finish the complete vaccination course of three injections.
Preverite, če ste v okviru cepljenja prejeli vse tri predpisane odmerke.
Anaphylaxis, allergic reactions including anaphylactoid reactions and mimicking serum sickness
Bolezni imunskega sistema anafilaksijske, alergijske reakcije vključno z anafilaktoidnimi reakcijami in serumski bolezni podobno stanje
Cases of overdose have been reported during post-marketing surveillance.
Med spremljanjem cepiva po pridobitvi dovoljenja za promet so poročali o primerih prevelikega odmerjanja.
As with all injectable vaccines, appropriate medical treatment and supervision should always be readily available in case of a rare anaphylactic event following the administration of the vaccine.
Kot pri vseh drugih parenteralnih cepivih mora biti zaradi redke možnosti anafilaktične reakcije na voljo ustrezno zdravljenje in zagotovljeno opazovanje osebe po cepljenju.
Blood and lymphatic system disorders
Bolezni krvi in limfatičnega sistema redki limfadenopatija
Side effects occurred very rarely during clinical studies or routine use of the vaccine or with individual hepatitis A and hepatitis B vaccines include:
Neželeni učinki se zelo redko pojavijo med kliničnimi študijami ali rutinskim cepljenjem s cepivom Twinrix ali enovalentnim cepivom proti hepatitisu A ali hepatitisu B.
As indicated in section 2, a poor response to the vaccine, possibly without achieving protection against hepatitis B, is more common in older people, men rather than women, smokers, obese people, and people with long standing illnesses, or people on some type of drug treatments.
Kot je opisano v poglavju 2, se slab odziv na cepivo, lahko tudi brez dosežene zaščite proti hepatitisu B, pojavi bolj pogosto pri starejših osebah, pogosteje pri moških kot pri ženskah, kadilcih,
• Numbness or weakness of the arms and legs (neuropathy), paralysis
• otrplost ali šibkost rok in nog (nevropatija), paraliza,
• Fourth dose:
• četrti odmerek:
A poor response to the vaccine, possibly without achieving protection against hepatitis B, has also been observed in older people, men rather than women, smokers, obese people, and people with long standing illnesses, or people on some type of drug treatments.
Pri osebah s prekomerno telesno maso so poročali o slabem odzivu na cepivo, tudi brez dosežene zaščite proti hepatitisu A. Slabši odziv na cepivo, tudi brez dosežene zaščite proti hepatitisu B, so opazili tudi pri starejših osebah, pogosteje pri moških kot pri ženskah, kadilcih, osebah s prekomerno telesno maso, osebah z dolgotrajnimi boleznimi ali osebah, ki jemljejo določena zdravila.
• Multiple sclerosis, swelling of the spinal cord (myelitis)
• multipla skleroza, oteklost hrbtenjače (mielitis),
As with any vaccine, a protective immune response may not be elicited in all vaccinees.
Kot cepljenje s katerim koli cepivom lahko tudi cepljenje s cepivom Twinrix za odrasle ne izzove zaščitnega imunskega odgovora pri vseh cepljenih osebah.
Syncope (fainting) can occur following, or even before, any vaccination especially in adolescents as a psychogenic response to the needle injection.
Po vsakem cepljenju ali celo pred njim se lahko pojavi sinkopa (omedlevica), zlasti pri mladostnikih,
1 pre-filled syringe + 1 needle 1 dose (1 ml)
1 napolnjena injekcijska brizga + 1 igla 1 odmerek (1 ml)
• Pain and redness at the injection site
• bolečina in rdečina na mestu vboda,
The seroprotection rate against hepatitis B after the administration of Twinrix Adult was 92% and 56% at 7 and 48 months respectively, versus 80% and 43% after the GlaxoSmithKline Biologicals monovalent 20µg hepatitis B vaccine, and 71% and 31% after another licensed monovalent 10µg hepatitis B vaccine.
mesecih in 56 % po 48 mesecih, po dajanju monovalentnega 20 µg cepiva proti hepatitisu B izdelovalca GlaxoSmithKline Biologicals pa 80 in 43 % (po 7 in po 48 mesecih) ter 71 in 31 % po dajanju nekega drugega monovalentnega 10 µg cepiva proti hepatitisu B z dovoljenjem za promet.
25 pre-filled syringes + 25 needles 25 x 1 dose (1 ml)
25 napolnjenih injekcijskih brizg + 25 igel 25 x 1 odmerek (1 ml)
• Purple or reddish-purple bumps on the skin (lichen planus), serious skin rashes (erythema multiforme), hives
• škrlatne ali rdeče-škrlatne izbokline na koži (lihen planus), močan kožni izpuščaj
Twinrix Adult is a white, slightly milky liquid presented in a glass pre-filled syringe (1 ml).
Cepivo Twinrix za odrasle je bela, rahlo mlečna tekočina v stekleni napolnjeni injekcijski brizgi
Re-suspension of the vaccine to obtain a uniform hazy white suspension
Kako pretresti cepivo, da dobimo enotno, motno belo suspenzijo
Exceptionally the vaccine may be administered subcutaneously in patients with thrombocytopenia or bleeding disorders.
Twinrix za odrasle se lahko izjemoma aplicira podkožno pri osebah s trombocitopenijo ali motnjami strjevanja krvi.
Adverse events reported following overdosage were similar to those reported with normal vaccine administration.
Neželeni učinki so bili podobni tistim po navadnem cepljenju.
The 0, 7 and 21 day primary schedule plus a fourth dose at month 12 is for use in exceptional circumstances in adults.
V izjemnih okoliščinah se pri odraslih lahko uporabi osnovno shemo cepljenja (0, 7. in 21.dan) z dodatnim četrtim odmerkom 12 mesecev po prvem odmerku.
• First dose:
• prvi odmerek:
• Fever equal to or greater than 37.5°C
• okužba zgornjih dihalnih poti, • zvišana telesna temperatura do 37.5°C ali višja.
Twinrix Adult can also be given as a total of three doses over 1 month.
6 mesecev po prvem odmerku S cepivom Twinrix za odrasle ste lahko cepljeni tudi z vsemi tremi odmerki v enem mesecu.
- The active substances are: Hepatitis A virus (inactivated)1,2
1 odmerek (1 ml) vsebuje: Virus hepatitisa A (inaktivirani)1,2
• Diarrhoea, nausea
• driska, siljenje na bruhanje,
Twinrix Adult is indicated for use in non immune adults and adolescents 16 years of age and above who are at risk of both hepatitis A and hepatitis B infection.
4.1 Terapevtske indikacije Cepivo Twinrix za odrasle je indicirano za uporabo pri neimunih odraslih in mladostnikih, starih 16 let in več, pri katerih obstaja tveganje za okužbo z virusom hepatitisa A in virusom hepatitisa B. 4.2 Odmerjanje in način uporabe
How to store Twinrix Adult
Kako uporabljati cepivo Twinrix za odrasle
When re-suspended, the vaccine will have a uniform hazy white appearance.
Pred uporabo je treba cepivo pretresti, da ponovno postane enotnega, motno belega videza.
PHARMACEUTICAL FORM Suspension for injection.
FARMACEVTSKA OBLIKA suspenzija za injiciranje motna bela suspenzija
• Second dose:
• drugi odmerek:
NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION Twinrix Adult, suspension for injection
IME ZDRAVILA IN POT(I) UPORABE Twinrix za odrasle suspenzija za injiciranje HAB cepivo i.m.